LONDON, ON, June 3, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (US:NDVAF) has successfully received an amended license from Health Canada for three additional grow rooms and three additional processing rooms, bringing the company’s annual cultivation capacity to approximately 1,000kg. The three newly licensed rooms will be immediately populated with plants, using advanced aeroponic grow technology, with the first harvest expected in less than 10 weeks. The Company has completed the video evidence package for an additional five rooms, including additional processing space, with the expectation the rooms will come online in Q3 2019, subject to Health Canada approval. Once all eight rooms are online, Indiva’s annual flower capacity will be approximately 3,000kg.
The amended license will further strengthen Indiva’s position in the domestic and international cannabis industry, by allowing an expanded supply of quality products to patients as well as provincial wholesalers. This expansion will directly serve the growing demand for Indiva products including the company’s current line of pre-rolls available through the OCS and licensed retailers in Ontario. The increased flower capacity will also serve as raw material for Indiva’s 70 tonne extraction facility planned for 2019, and ultimately serves as a high quality input for the Company’s upcoming release of concentrates, chocolates, sugar and various other cannabis derivative items, when the law permits.
Indiva continues to execute on its expansion plans, and this increase in production capacity gives us greater bandwidth to service the demand for quality cannabis products in Canada.
Niel Marotta, President and CEO
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva’s wholly owned subsidiary is licensed under the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.